ES2195922T3 - Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos. - Google Patents

Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos.

Info

Publication number
ES2195922T3
ES2195922T3 ES00949297T ES00949297T ES2195922T3 ES 2195922 T3 ES2195922 T3 ES 2195922T3 ES 00949297 T ES00949297 T ES 00949297T ES 00949297 T ES00949297 T ES 00949297T ES 2195922 T3 ES2195922 T3 ES 2195922T3
Authority
ES
Spain
Prior art keywords
daunorububine
antimetabolites
compounds
includes derivatives
synergic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00949297T
Other languages
English (en)
Inventor
Maria Cristina Geroni
Marina Ripamonti
Michele Caruso
Antonino Suarato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia SpA filed Critical Pharmacia Italia SpA
Application granted granted Critical
Publication of ES2195922T3 publication Critical patent/ES2195922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un producto que contiene una antraciclina alquilante de fórmula Ia o Ib: **(Fórmula)** y un compuesto antimetabolito como preparación combinada para uso simultáneo, separado o secuencial en el tratamiento de tumores.
ES00949297T 1999-07-19 2000-07-10 Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos. Expired - Lifetime ES2195922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9916882.5A GB9916882D0 (en) 1999-07-19 1999-07-19 Antitumor synergistic composition

Publications (1)

Publication Number Publication Date
ES2195922T3 true ES2195922T3 (es) 2003-12-16

Family

ID=10857494

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00949297T Expired - Lifetime ES2195922T3 (es) 1999-07-19 2000-07-10 Composicion sinergica que comprende derivados de daunorrubicina y compuestos antimetabolitos.

Country Status (10)

Country Link
EP (1) EP1200099B1 (es)
JP (1) JP2003504394A (es)
AT (1) ATE241991T1 (es)
AU (1) AU6271100A (es)
DE (1) DE60003189T2 (es)
DK (1) DK1200099T3 (es)
ES (1) ES2195922T3 (es)
GB (1) GB9916882D0 (es)
PT (1) PT1200099E (es)
WO (1) WO2001005382A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114654D0 (en) * 2001-06-15 2001-08-08 Pharmacia & Upjohn Spa Anti-tumor compound

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853221A (en) * 1980-11-13 1989-08-01 Warner-Lambert Company Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
US5919816A (en) * 1994-11-14 1999-07-06 Bionumerik Pharmaceuticals, Inc. Formulations and methods of reducing toxicity of antineoplastic agents
GB9806324D0 (en) * 1998-03-24 1998-05-20 Pharmacia & Upjohn Spa Antitumour synergetic composition
GB9904387D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9904386D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives

Also Published As

Publication number Publication date
WO2001005382A1 (en) 2001-01-25
JP2003504394A (ja) 2003-02-04
AU6271100A (en) 2001-02-05
WO2001005382A8 (en) 2001-04-12
EP1200099B1 (en) 2003-06-04
ATE241991T1 (de) 2003-06-15
EP1200099A1 (en) 2002-05-02
DE60003189T2 (de) 2003-12-18
DK1200099T3 (da) 2003-07-21
GB9916882D0 (en) 1999-09-22
PT1200099E (pt) 2003-08-29
DE60003189D1 (de) 2003-07-10

Similar Documents

Publication Publication Date Title
MY135985A (en) Antitumor synergistic composition.
DZ2614A1 (fr) Compositions pharmaceutiques topiques contenant des dérivés de résorcinol.
AR020345A1 (es) Pirazol-carboxanilidas, procedimiento para su obtencion, composiciones, empleo de dichos compuestos y procedimiento para la lucha contra microorganismos indeseables, y procedimiento para la obtencion de dichas composiciones.
ATE247470T1 (de) Neue substituierte imidazolverbindungen
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BG106586A (en) Pyrazolopyramidines as therapeutic agents
PL348451A1 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
ATE228361T1 (de) Reduzierung der kardiotoxizität von antitumormitteln mit manganverbindungen
BR9908391A (pt) Composição antitumural contendo uma combinação sinergìstica de um derivado de antraciclina com um derivado de camptotecina
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
HRPK20030734B3 (en) A combination comprising combretastatin and anticancer agents
ATE297904T1 (de) Halo-alkoxycarbonylverbindungen
DE60112960D1 (de) Kondensierte pyridoindolderivate
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
DK0613687T3 (da) Anvendelse af pregnanderivat til behandling af tumorer
DK1200099T3 (da) Synergistisk sammensætning indeholdende daunorubicinderivater og antimetabolitforbindelser
MXPA02012209A (es) Terapia combinada contra tumores que comprende derivados de bistamicina acriloilo substituida y agentes de alquilacion.
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
AU6755301A (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites
BR0008454A (pt) Composição sinergìstica anti-tumoral
GEP20074097B (en) Use of specific dose of fondaparinux sodium for the treatment of acs
BR9508521A (pt) Inibição da biossintese de leucotrienos com derivados de uréia
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents